Meeting
2020 ASCO Virtual Scientific Program
Genetic testing and referral patterns of non-BRCA mutation carriers at increased or uncertain risk of ovarian cancer.
Authors
Sarah S. Lee
New York University School of Medicine, New York, NY
Sarah S. Lee , Katherine Baumann , Bhoomi Bhuptani , Sarah Turecamo , Julia Anne Smith , Bhavana Pothuri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1585)
DOI
10.1200/JCO.2020.38.15_suppl.1585
Abstract #
1585
Poster Bd #
77
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Performance of mutation risk prediction models in a racially diverse multi-gene panel testing cohort.
First Author: Gregory Idos
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos
Poster
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
First Author: Allison W. Kurian
Poster
2016 ASCO Annual Meeting
Next-generation sequencing in BRCA1/2-negative breast and ovarian cancer families.
First Author: Jan Hauke